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We describe the first case of cervical syphilitic spondylodiscitis associated with neurosyphilis. The patient gave his informed consent for the report according to the Declaration of Helsinki.
A 61-year-old Caucasian man presented a 2-month history of fatigue, night sweats and cervical pain. Two months before admission, he suddenly had bilateral deafness associated with a rash on his chest that lasted 2 weeks. At admission, physical examination revealed cervical and axillary lymphadenopathy (lymph nodes 12 cm); neurological examination was normal and cervical stiffness was absent. Laboratory tests revealed elevated white blood cell count, 11 400/mm 3 ; CRP level 37 mg/l; hepatic cytolysis and cholestasis; and hypergammaglobulinaemia, 24 g/l. Microbiological tests, including blood and urine culture and tests for HIV, tuberculosis, viral hepatitis C and B and toxoplasmosis, gave negative results, but cervical spine CT scan and MRI findings revealed typical C2C3 spondylodiscitis ( Fig. 1A i.m. injections of benzathinepenicillin (2.4 MU). Two months after the end of the treatment, hearing was improved, and cytolysis, cholestasis and cervical pain disappeared. The lumbar puncture revealed 9 cells/mm 3 .
Cervical MRI revealed marked improvement ( Fig. 1C  and D) . Syphilis remains a significant health concern in Europe. The incidence was low between 1950 and 1990, but increased in high-income settings from the beginning of the 21st century [1] . Twelve million people are infected every year [4] . The only definite criterion for diagnosis of active syphilis is the detection of T. pallidum on darkfield microscopy, direct fluorescent antibody tests or PCR of diseased lesion samples [5] . However, a presumptive diagnosis is possible with serological tests for syphilis: non-treponemal tests such as VDRL, micro-precipitation reaction (MPR) and rapid plasma reagin (RPR) tests, and treponemal tests such as TPHA, and fluorescent trepo- Cases of musculoskeletal localizations are rare in acquired syphilis (<1%), but are more frequent in congenital syphilis. The predominant localizations are the skull, sternum and long bones [8] . A few cases of syphilitic spondylitis, mostly lumbar, have been described [911] , but none is recent. In all cases, the diagnosis was difficult but treatment was efficient. No case of   FIG. 1 Cervical MRI showed typical lesions of spondylodiscitis. (A and B) Cervical MRI revealed high signal intensity of the C2C3 disc and C2 bodies with anterior lesions of surrounding tissues from C1 to C3 on T 2 -weighted images (A) and low signal intensity on T 1 -weighted images of the vertebral body of C2 and gadolinium enhancement in the C2 lower plate and C2C3 disc (B). These signs were typical of an inflammatory process, which corroborated the diagnosis of spondylodiscitis. (C and D) Radiographic evidence of improvement 2 months after treatment. syphilitic spondylodiscitis has been reported. All other symptoms for our patient were due to syphilis, as confirmed by improvement with treatment. Deafness was due to neurosyphilis or labyrinthitis. A recent study showed that 10% of patients with secondary syphilis had hepatic involvement [12] . Acquired syphilis must be considered in case of spondylodiscitis associated with hearing loss.
Rheumatology key message
. Acquired syphilis must be considered in cases of osseous involvement associated with hearing loss. Cryptococcal meningitis in an HIV-negative patient with rheumatoid arthritis treated with rituximab SIR, mAb agents, such as infliximab and rituximab, are increasingly prescribed for treatment of RA. We present a rare case of cryptococcal meningitis in a patient with severe RA after treatment with rituximab and, some significant time before that, infliximab.
A retired 70-year-old man with a 12-year history of RA was admitted with a 1-month history of reduced mobility, confusion, decreased appetite and weight loss. He had previously received infliximab over an 8-year period-a total of 39 infusions-the last dose being administered 7 months before admission. He subsequently received two doses of rituximab 4 months before admission. Other medications included prednisone 10 mg daily and MTX 7.5 mg weekly.
During admission he became increasingly confused, pyrexial and developed a left-sided facial palsy with slurred speech. A CT scan showed ischaemic changes and old left basal ganglia infarct. He was started on aspirin for presumed cerebrovascular accident.
Over the following 2 weeks, he remained confused and developed bilateral lower motor neurone VIIth nerve palsy, dysarthria, globally reduced power and worsening of visual acuity. Repeat CT head showed no new features. Lumbar puncture (LP) examination demonstrated raised leucocytes at 60/mm 3 with a lymphocytic predominance of 99%, low-glucose CSF : serum ratio (17%) and raised protein (0.47 g/l). He was commenced on acyclovir and transferred to an infectious diseases unit. Repeat LP showed opening pressure (OP) 19 cm, lymphocytes 48/mm 3 , with Cryptococcal antigen (CRAG) positive at titre of 1 : 2048. Cryptococcus neoformans was subsequently cultured and speciated as var neoformans using ITS1 and D2 primers. Sensitivity testing showed minimum inhibitory concentrations (MICs) as follows: flucytosine 8 mg/l (break point < 1 mg/l), fluconazole 32 mg/l (<8 mg/l), amphoterocin 0.03 mg/l (<0.125 mg/l), itraconazole 0.25 mg/l (<0.125 mg/l) and voriconazole 0.5 mg/l (<0.125 mg/l). MRI brain showed non-specific white matter changes and old left basal ganglia infarct. HIV test was negative and full blood count was normal with no neutropenia (initial neutrophils 4.8 m/l) throughout admission. Serum CRAG was initially positive (1 : 4096), but repeated blood cultures failed to grow Cryptococcus.
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